BIO-Europe 2025Products & Services Interleukin-2 based immunotherapy product for inhalation - well tolerated
Interleukin-2 based immunotherapy product for inhalation - well tolerated
Exhibitor
Immunservice GmbH
excellent quality of life and significant long-term control of tumours in the respiratory tract /lung, high need, Orphan Designation for renal cell cancer